[go: up one dir, main page]

MX2016005092A - Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. - Google Patents

Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.

Info

Publication number
MX2016005092A
MX2016005092A MX2016005092A MX2016005092A MX2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A
Authority
MX
Mexico
Prior art keywords
methods
pharmaceutical compositons
vaginal
estradiol pharmaceutical
vaginal inserted
Prior art date
Application number
MX2016005092A
Other languages
English (en)
Inventor
A Bernick Brian
Louise Cacace Janice
M Amadio Julia
H R Persicaner Peter
Thorsteinsson Thorsteinn
D Sanscilio Frederick
Irani Neda
Original Assignee
Therapeuticsmd Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/099,562 external-priority patent/US8987237B2/en
Application filed by Therapeuticsmd Inc filed Critical Therapeuticsmd Inc
Publication of MX2016005092A publication Critical patent/MX2016005092A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

De conformidad con varias modalidades de la presente descripción, se proporcionan composiciones farmacéuticas que comprenden estradiol solubilizado. En varias modalidades, dichas composiciones se encapsulan en cápsulas blandas que pueden insertarse en la vagina para el tratamiento de la atrofia vulvovaginal.
MX2016005092A 2013-10-10 2014-10-22 Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. MX2016005092A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361889483P 2013-10-10 2013-10-10
US201361894411P 2013-10-22 2013-10-22
US14/099,562 US8987237B2 (en) 2011-11-23 2013-12-06 Natural combination hormone replacement formulations and therapies
US201461932140P 2014-01-27 2014-01-27
PCT/US2014/061811 WO2015073177A1 (en) 2013-10-10 2014-10-22 Vaginal inserted estradiol pharmaceutical compositons and methods

Publications (1)

Publication Number Publication Date
MX2016005092A true MX2016005092A (es) 2016-08-17

Family

ID=53140634

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005092A MX2016005092A (es) 2013-10-10 2014-10-22 Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.

Country Status (2)

Country Link
MX (1) MX2016005092A (es)
WO (1) WO2015073177A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
WO2021111385A2 (en) 2019-12-06 2021-06-10 Prathima Chowdary Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1300799A (en) * 1997-11-03 1999-05-24 Deschutes Medical Products, Inc. Pessary with medicated cartridge
MX367596B (es) * 2012-01-26 2019-08-27 Therapeuticsmd Inc Tratamientos transdermicos de sustitucion hormonal.
US20130224268A1 (en) * 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same

Also Published As

Publication number Publication date
WO2015073177A8 (en) 2016-07-07
CA2926342A1 (en) 2015-05-21
WO2015073177A1 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
MX2014015899A (es) Capsula de estradiol soluble para insercion por via vaginal.
MX2015017964A (es) Inhibidores de bromodominio.
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
IN2013MU03583A (es)
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
IN2015MN00478A (es)
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2020004205A (es) Composiciones antibioticas de ceftolozano.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
AU2016356504A8 (en) 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
PH12015502564B1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
MX2015016603A (es) Composiciones de corticosteroides.
EA201492238A1 (ru) Композиция мизопростола
MX2022002614A (es) El uso de un pesario que comprende una capsula que contiene estradiol y un agente solubilizante para el tratamiento de la atrofia vulvovaginal.
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
UA92840U (uk) Дегідратаційно-дегреасингаційний розчин для пластинації анатомічних препаратів
HK1262604A1 (en) Vaginal inserted estradiol pharmaceutical compositions and methods
IN2013CH02437A (es)
MY180947A (en) Ceftolozane antibiotic compositions
MX2016001694A (es) Formulacion de vacuna de sacarido.